期刊文献+

人血浆蛋白多烯紫杉醇纳米粒子的自组装及对肿瘤的靶向性 被引量:3

Preparation and characterization of human serum albumin-docetaxel nanoparticles
下载PDF
导出
摘要 目的:提高多烯紫杉醇的溶解度,提高其靶向性能。方法用二硫键断裂法制备人血清白蛋白多烯紫杉醇纳米粒子,并用电镜进行观察。对粒子载药量、稳定性及粒子对肿瘤部位趋向性进行表征。结果二硫键断裂法成功组装了白蛋白-多烯紫杉醇纳米粒子。电镜观察该纳米粒子外貌为80~100 nm左右的球形粒子,高效液相和蛋白质定量检测多烯紫杉醇载药量可达21.5%。结果白蛋白多烯紫杉醇纳米制剂可显著提高多烯紫杉醇的溶解度,提高对肿瘤靶向性。结论白蛋白-多烯紫杉醇纳米粒子对肿瘤细胞具有良好的靶向作用,具有临床运用的潜在价值。 Objective To improve the solubility of docetaxel and reduce its toxic and side effects, and to improve the targe-ting capability of docetaxel. Methods The human serum albumin-docetaxel nanoparticles were prepared by the disulfide bond reduction method, and were observed by electron microscope. The drug loading efficiency, stability and targeting capability of nanopar-ticles were explored. Results Albumin-docetaxel nanoparticles were successfully fabricated through disulfide bond reduction. Albumin-docetaxel nanoparticles were about 80-100 nm in diameter, and the loading of docetaxel was up to 21.5%. The marrow depression toxic-ity of albumin-docetaxel nanoparticles, which could accumulate at the tumor site, was reduced. Conclusion Albumin-docetaxel nano-particles have good targeting effect on tumor cells, which have potential value in clinical application.
出处 《东南国防医药》 2016年第5期468-471,共4页 Military Medical Journal of Southeast China
基金 南京军区南京总医院院管课题(2013055)
关键词 血浆蛋白 多烯紫杉醇 纳米粒子 自组装 肿瘤靶向 human serum albumin docetaxel nanoparticles self-assembly tumor target
  • 相关文献

参考文献3

二级参考文献38

  • 1Hobson B, Denekamp J. Endothelial proliferation in tumors andnormal tissues: continuous labelling studies[J]. Br J Cancer,1984,49:405-413.
  • 2Lowder JN,Meeker DC,Campbell M,et al. Studies on B lymphoidtumor treated with monoclonal anti-idiotype antibodies: Correlationwith clinical responses[ J]. Bleed, 1987,69:199-210.
  • 3Epenetos AA, Snook D, Durbin H, et al. Limitation of radiolabeledmoncoclonal antibodies for loealization of human neoplasm [ J ].Cancer Res, 1986,46:3283-3191.
  • 4Jain RK, Bazter LT. Mechanism of heterogeneous distribution ofmonoclonal antibodies and other macromolecules in tumors:signifi-cance of elevated in terstitial pressure[ J ]. Cancer Res, 1988,48:7022-7032.
  • 5Juweid M, Neumann R, Perez-Bacete MJ,et al. Microphamacologyof monoclonal antibodies in solid tumors:direct experimental evi-dental evidence for a binding site barrier[J]. Cancer Res, 1992,52:5144-5153.
  • 6Burrows FJ, Thorpe PE. Eradication of large solid tumors in micewith an immunotoxin directed against tumor vasculature[ J]. ProcNatl Acad Sci USA,1994,90:8996-9000.
  • 7McAlister KA. Endoglin,a TGF-beta binding protein of endothelialcells,is the gene for hereditary haemorrhagic telangiectasia type 1[J]. Nature Genet, 1994,8:345-351.
  • 8Gougos A,St Jacques S, Greaves A, et al. Identification of distinctepitopes of endoglin, an RGD-containing glycoprotein of endotheli-al cells,leukemic cells and syncytiotrophoblasts[J]. Int Immunol,1992,4:83-92.
  • 9O,Connell PJ,Mckenzie A,Ficicaro N,et al. Endoglin:a 180-kDendothelial cell and macrophage restricted differentiation molecule[ J ]. Clin Exp Immunol, 1992,90:154-159.
  • 10Buhring JHJ, Muller CA, Letate M, et al. Endoglin is expressed ona subpopolation of immature erythroid cells or normal bone marrow[J]. Leukemia, 1991,5:841-847.

共引文献12

同被引文献4

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部